ESC2025 Premium Access

Optimizing beta-blocker therapy in acute heart failure: insights from a nationwide registry

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Congress Presentation

About the speaker

Doctor Heayoung Shin

Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul (Korea (Republic of))
0 follower

7 more presentations in this session

Levosimendan therapy and mortality predictors in end-stage heart failure patients beyond advanced therapeutic options

Speaker: Doctor S. Jimenez-Marrero (Barcelona, ES)

Thumbnail

Prognostic impact of urine output after catecholamine administration in cardiogenic shock due to acute decompensated heart failure

Speaker: Doctor S. Kawanami (Sakai, JP)

Thumbnail

Impact of in-hospital initiation of angiotensin receptor-neprilysin inhibition on left ventricular reverse remodeling in acute heart failure: an insight from PREMIER trial

Speaker: Assistant Professor T. Takahashi (Tokushima, JP)

Thumbnail

Impact and course of albuminuria in acute heart failure according to left or right sided heart failure phenotype

Speaker: Mr J. Deniz Rosario (Las Palmas de Gran Canaria, ES)

Thumbnail

Prognostic value of energetic hemodynamics in acute heart failure: beyond conventional measures

Speaker: Doctor H. Chang (Taipei, TW)

Thumbnail

Access the full session

In-hospital care of acute heart failure

Speakers: Doctor H. Shin, Doctor S. Jimenez-Marrero, Doctor S. Kawanami, Assistant Professor T. Takahashi, Mr J. Deniz Rosario...
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations